跳至主要内容
临床试验/NCT01947127
NCT01947127已完成不适用

Can Venous Lactate Predict the Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients Without Hemodynamic Shock in Emergency Department?

Chulalongkorn University1 个研究点 分布在 1 个国家目标入组 458 人开始时间: 2013年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
458
试验地点
1
主要终点
Proportion of the Patients Who Require Vasopressor/Mechanical Ventilator

研究概览

简要总结

To investigate the role of initial venous lactate in predicting the severity progression to overt septic shock and 30-day mortality in non-elderly patients without hemodynamic shock who suspected to have acute infections.

详细描述

Blood lactate is one of the markers that can predict the organ failures and mortality in emergency department (ED) patients with sepsis. Regarding its predictive role in the clinical deterioration in normotensive sepsis patients, a recent prospective observational study of the patients with moderately-high serum lactate (2.0-3.9 mmol/L) showed that one-forth of the patients eventually developed progressive organ dysfunctions or required vasopressor or mechanical ventilator. Unfortunately, low serum lactate (< 2.5 mmol/L) was still found up to 50% of overt septic shock patients, even in vasopressor-dependent cases. For the prognostic role on mortality, numbers of articles showed that blood lactate can also predict death in sepsis patients, especially in those who are elderly and critically-ill. However, no previous study was done in younger patients since lactate kinetics in the body may differ among the age groups. The primary aim of our study is to investigate the role of initial venous lactate levels in predicting the chance of severity progression to overt septic shock especially in non-elderly patients who suspected to have acute infections and without hemodynamic shock in ED. The secondary outcomes are to evaluate its prognostic role on hospital length of stay and 30-day mortality of this target population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 to 65 years
  • Confirmed or suspected diagnoses of acute infections (within 7 days)
  • Major infections (e.g. Acute pyelonephritis, Acute bronchitis/pneumonia, Acute hepatobiliary tract infections, intrabdominal abscesses, meningitis and other central nervous system infections, soft tissue infections involving more than 10 square centimeters of the skin surface or deeper down beyond the dermis, significant tropical infections; dengue fever, leptospirosis, typhus fevers, or high fever from any infectious sources)
  • Systolic blood pressure more than 90 mmHg at presentation
  • Mean arterial pressure more than 70 mmHg at presentation

排除标准

  • Duplicated cases that have participated in this study during the study period
  • Overt organ hypoperfusion (e.g. cold, clammy or mottling skin, altered mental status; Glasgow Coma Scale equal to or less than 12 or decrease > 1 compared with the baseline)
  • Pulse oximetry equal to or less than 90% at ambient air
  • received intravenous fluid more than 10 ml/kg prior to the venous blood sampling
  • received intravenous antibiotics for more than 1 hours prior to the venous blood sampling
  • Minor infections (e.g. uncomplicated upper respiratory tract infections, gastroenteritis, minor skin infections)
  • currently taking antiretroviral drugs
  • having or suspicious of having seizures in the past 72 hours

结局指标

主要结局

Proportion of the Patients Who Require Vasopressor/Mechanical Ventilator

时间窗: 72 hours after venous lactate measurement

Proportion of the patients in each cohort who require vasopressor/mechanical ventilator to maintain their vital signs in the next 72 hours after venous lactate measurement.

次要结局

  • Hospital Length of Stay(Patients will be followed for the duration of hospital stay, an expected average of 7 days)
  • All-cause Mortality Rates(30 days after the day of presentation to the emergency department)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Khrongwong Musikatavorn, MD.

Khrongwong Musikatavorn, MD

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验